trt and glp 1 Day 2 of coming off GLP- 1. I’m documenting this journey in real time—the wins, the struggles, and everything in between. My goal isn’t just to get through this transition, but to build a TRT Meets GLP-1: Metabolic Dynamic

Description

The exact timing and extent of results can vary from person to person

After a 4-week screening period, participants were randomly assigned, 1:1:1:1:1, to once-weekly 2.5 mg, 5 mg, 10 mg or 15 mg VK2735 or placebo for 13 weeks

Contributor Prajakt Mahajan, Head of Underwriting Services & Solutions, US Life [1] Pharmacotherapy of obesity: an update on the available medications and drugs under investigation, Marlene Chakhtoura, Rachelle Haber, Malak Ghezzawi, Caline Rhaydem, Raya Tcheroyan and Christos Mantzoros, available at: 2023 TheAuthors.PublishedbyElsevierLtd

Acta Endocrinol (Buchar)

Iacobellis G, Villasante Fricke AC (2020) Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity